Skip to main content
ARGX logo

ARGX

argenx SE Sponsored ADR

$939.68

3.32%

Trade Ideas Performance

Latest Closed Trade Idea

$939.68

3.32%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

35

Social

55

About

Events of argenx SE Sponsored ADR (ARGX)

In the past six months, argenx SE's stock has been influenced by several key events. The company reported strong first-quarter 2026 financial results and FDA approvals for VYVGART and VYVGART Hytrulo, positively influencing the stock. Karen Massey was appointed as the new CEO, with Tim Van Hauwermeiren transitioning to Board Chairperson. Argenx shares fell after the company dropped trials for an eye-disease drug in December 2025. Strong patient uptake of VYVGART has consistently driven revenue growth.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
argenx SE (ARGX) Live Stock Price, Chart & Financial News | Edge Hound